Role of the wbt locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity

被引：81

作者：

Raynaud, Catherine

Meibom, Karin L.

Lety, Marie-Annick

Dubail, Iharilalao

Candela, Thomas

Frapy, Eric

Charbit, Alain

机构：

[1] Univ Paris Descartes, Fac Med Rene Descartes, F-75015 Paris, France

[2] INSERM, U570, Unite Pathogenie Infect Syst, F-75015 Paris, France

[3] CNRS, URA2172, Unite Toxines & Pathogenie Bacterienne, F-75724 Paris, France

来源：

INFECTION AND IMMUNITY | 2007年 / 75卷 / 01期

关键词：

D O I：

10.1128/IAI.01429-06

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Francisella tularensis is a highly infectious bacterial pathogen, responsible for the zoonotic disease tularemia. We screened a bank of transposon insertion mutants of F. tularensis subsp. holarctica LVS for colony morphology alterations and selected a mutant with a transposon insertion in wbtA, the first gene of the predicted lipopolysaccharide O-antigen gene cluster. Inactivation of wbtA led to the complete loss of O antigen, conferred serum sensitivity, impaired intracellular replication, and severely attenuated virulence in the mouse model. Notably, this mutant afforded protection against a challenge against virulent LVS.

引用

收藏

页码：536 / 541

页数：6

相关论文

共 23 条

[1] Functional analysis of genes responsible for the synthesis of the B-band O antigen of Pseudomonas aeruginosa serotype O6 lipopolysaccharide [J].

Bélanger, M ;

Burrows, LL ;

Lam, JS .

MICROBIOLOGY-UK, 1999, 145 :3505-3521

[2] EVALUATION OF LIVE TULAREMIA VACCINE PREPARED IN A CHEMICALLY DEFINED MEDIUM [J].

CHAMBERL.RE .

APPLIED MICROBIOLOGY, 1965, 13 (02) :232-&

[3] INCREASED ENCAPSULATION AND VIRULENCE OF FRANCISELLA-TULARENSIS LIVE VACCINE STRAIN (LVS) BY SUBCULTURING ON SYNTHETIC MEDIUM [J].

CHERWONOGRODZKY, JW ;

KNODEL, MH ;

SPENCE, MR .

VACCINE, 1994, 12 (09) :773-775

[4] Mice intradermally-inoculated with the intact lipopolysaccharide, but not the lipid A or O-chain, from Francisella tularensis LVS rapidly acquire varying degrees of enhanced resistance against systemic or aerogenic challenge with virulent strains of the pathogen [J].

Conlan, JW ;

Vinogradov, E ;

Monteiro, MA ;

Perry, MB .

MICROBIAL PATHOGENESIS, 2003, 34 (01) :39-45

[5] Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen [J].

Conlan, JW ;

Shen, H ;

Webb, A ;

Perry, MB .

VACCINE, 2002, 20 (29-30) :3465-3471

[6] Isolation and characterization of Francisella novicida mutants defective in lipopolysaccharide biosynthesis [J].

Cowley, SC ;

Gray, CJ ;

Nano, FE .

FEMS MICROBIOLOGY LETTERS, 2000, 182 (01) :63-67

[7] Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production [J].

Cowley, SC ;

Myltseva, SV ;

Nano, FE .

MOLECULAR MICROBIOLOGY, 1996, 20 (04) :867-874

[8] USE OF IMMUNOELECTRON MICROSCOPY TO DEMONSTRATE FRANCISELLA-TULARENSIS [J].

GEISBERT, TW ;

JAHRLING, PB ;

EZZELL, JW .

JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (07) :1936-1939

[9] Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice [J].

Hartley, G ;

Taylor, R ;

Prior, J ;

Newstead, S ;

Hitchen, PG ;

Morris, HR ;

Dell, A ;

Titball, RW .

VACCINE, 2006, 24 (07) :989-996

[10] Use of transposon-transposase complexes to create stable insertion mutant strains of Francisella tularensis LVS [J].

Kawula, TH ;

Hall, JD ;

Fuller, JR ;

Craven, RR .

APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2004, 70 (11) :6901-6904